Background Drug-disease interactions are situations where pharmacotherapy may have a negative effect on patients’ comorbidities. In these cases, it can be necessary to avoid that drug, adjust its dose or monitor therapy. In the Netherlands, pharmacists have developed a best practice how to systematically evaluate drug-disease interactions based on pharmacological considerations and implement recommendations for specific drug-disease interactions. Aim To describe the development of recommendations for drug-disease interactions and the implementation in prescribing and dispensing practice in the Netherlands. Setting Pharmacies and physicians’ practices in primary care and hospitals in the Netherlands. Development A multi-disciplinary expert panel assessed if diseases had clinically relevant drug-disease interactions and evaluated drug-disease interactions by literature review and expert opinion, and subsequently developed practice recommendations. Implementation The recommendations were implemented in all clinical decision support systems in primary care and hospitals throughout the Netherlands. Evaluation Recommendations were developed for 57 diseases and conditions. Cardiovascular diseases have the most drug-disease interactions (n = 12, e.g. long QT-syndrome, heart failure), followed by conditions related to the reproductive system (n = 7, e.g. pregnancy). The number of drugs with recommendations differed between 6 for endometriosis and tympanostomy tubes, and up to 1171 in the case of porphyria or even all drugs for pregnancy. Conclusion Practice recommendations for drug-disease interactions were developed, and implemented in prescribing and dispensing practice. These recommendations support both pharmacists and physicians by signalling clinically relevant drug-disease interactions at point of care, thereby improving medication safety. This practice may be adopted and contribute to safer medication use in other countries as well.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
van Loon WE, Borgsteede SD, Baas GW, Kruijtbosch M, Buurma H, De Smet PAGM, et al. Nature and frequency of prescription modifications in community pharmacies: a nationwide study in the Netherlands. Br J Clin Pharmacol. 2021;87(3):1455–65.
Hailu BY, Berhe DF, Gudina EK, Gidey K, Getachew M. Drug related problems in admitted geriatric patients: the impact of clinical pharmacist interventions. BMC Geriatr. 2020;20(1):13.
Garin N, Koyanagi A, Chatterji S, Tyrovolas S, Olaya B, Leonardi M, et al. Global multimorbidity patterns: a cross-sectional, population-based, multi-country study. J Gerontol A Biol Sci Med Sci. 2016;71(2):205–14.
Hopman P, Heins MJ, Korevaar JC, Rijken M, Schellevis FG. Health care utilization of patients with multiple chronic diseases in the Netherlands: Differences and underlying factors. Eur J Intern Med. 2016;35:44–50.
Royal Dutch Pharmacists Assosciation (KNMP). KNMP-richtlijn Medicatiebewaking [Guideline]. https://www.knmp.nl/patientenzorg/medicatiebewaking/knmp-richtlijn-medicatiebewaking Accessed 01 April 2021.
Kheshti R, Aalipour M, Namazi S. A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness. J Res Pharm Pract. 2016;5(4):257–63.
van Tongeren JMZ, Harkes-Idzinga SF, van der Sijs H, Atiqi R, van den Bemt BJF, Draijer LW, et al. The development of practice recommendations for drug-disease interactions by literature review and expert opinion. Front Pharmacol. 2020;11:707.
Dutch Foundation for Pharmaceutical Statistics (SFK). Data en feiten 2020 - Het jaar 2019 in cijfers. 2020.
CBS StatLine. Nabijheid voorzieningen; afstand locatie, regionale cijfers [updated 22 February 2021. https://opendata.cbs.nl/statline/#/CBS/nl/dataset/80305ned/table?fromstatweb. Accessed 11 May 2021
The Dutch College of General Practitioners (NHG). GPs and the Dutch healthcare system. https://www.nhg.org/english/gp-dutch-healthcare-system. Accessed: 11 May 2021
Buurma H, Bouvy ML, De Smet PA, Floor-Schreudering A, Leufkens HG, Egberts AC. Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther. 2008;33(1):17–23.
Nictiz. eHealth-monitor - Electronic data exchange and communication between healthcare providers 2019. https://www.nictiz.nl/wp-content/uploads/Theme-discussion-5-Electronic-data-exchange.pdf.
Cheung KC, de Bie J. Pharmacist in the WGBO. Practice, knowledge and expectations of pharmacists and pharmacy technicians for inclusion of the pharmacist in the WGBO.: KNMP/SIR; 2007.
van Mil JW. Pharmaceutical care in community pharmacy: practice and research in the Netherlands. Ann Pharmacother. 2005;39(10):1720–5.
Multidisciplinary. Richtlijn Overdracht van Medicatiegegevens in de keten - Revision 2018/2019 [Guideline]. https://www.knmp.nl/downloads/herziene-richtlijn-overdracht-van-medicatiegegevens-in-de-keten.pdf. Accessed: 11 May 2021
Vries T, Richir M, Tichelaar J. WHO Guide to Good Prescribing. The Politics of Medicines (e-Encyclopaedia). 2012. https://haiweb.org/encyclopaedia/who-guide-togood-prescribing/. Accessed 11 May 2021
Eppenga WL, Derijks HJ, Conemans JM, Hermens WA, Wensing M, De Smet PA. Comparison of a basic and an advanced pharmacotherapy-related clinical decision support system in a hospital care setting in the Netherlands. J Am Med Inform Assoc. 2012;19(1):66–71.
Becker ML, Baypinar F, Pereboom M, Lilih S, Kingma HJ, van der Hoeven RTM. Het positieve effect van klinische beslisregels getoond op het moment van voorschrijven. https://www.npfo.nl/artikel/het-positieve-effect-van-klinische-beslisregels-getoond-op-het-moment-van-voorschrijven. Accessed 11 May 2021
Zuidema S, Smalbrugge M, Bil W, Geelen R, Kok R, Luijendijk H, et al. Multidisciplinaire Richtlijn probleemgedrag bij dementie 2018. https://www.verenso.nl/richtlijnen-en-praktijkvoering/richtlijnendatabase/probleemgedrag-bij-mensen-met-dementie. Accessed 11 May 2021
Echeverry D, Duran P, Bonds C, Lee M, Davidson MB. Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2009;32(12):2156–60.
Derijks HJ, Heerdink ER, De Koning FH, Janknegt R, Klungel OH, Egberts AC. The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study. Pharmacoepidemiol Drug Saf. 2008;17(4):336–44.
Volksgezondheidenzorg.info Bilthoven: RIVM; 2021. https://www.volksgezondheidenzorg.info/. Accessed 18 May 2021
Heringa M, Floor-Schreudering A, Tromp PC, de Smet PA, Bouvy ML. Nature and frequency of drug therapy alerts generated by clinical decision support in community pharmacy. Pharmacoepidemiol Drug Saf. 2016;25(1):82–9.
Medicines Information Centre. Contra-indicatie aandoeningen. Royal Dutch Pharmacists Association (Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie, KNMP), the Netherlands. https://kennisbank.knmp.nl. Accessed: 4 June 2021
Borgsteede SD, Pham TKL, Eimermann VM, De Klerk S, Tsoi KY, (Eds.). Commentaren Medicatiebewaking; Health Base Foundation, the Netherlands. 2020. www.commentarenmedicatiebewaking.nl. Accessed 04 June 2021
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021.
Vinks AA, Peck RW, Neely M, Mould DR. Development and implementation of electronic health record-integrated model-informed clinical decision support tools for the precision dosing of drugs. Clin Pharmacol Ther. 2020;107(1):129–35.
Brabers AE, Van Dijk L, Bouvy ML, De Jong JD. Where to buy OTC medications? A cross-sectional survey investigating consumers' confidence in over-the-counter (OTC) skills and their attitudes towards the availability of OTC painkillers. BMJ Open. 2013;3(9):e003455.
Sinnige J, Korevaar JC, van Lieshout J, Westert GP, Schellevis FG, Braspenning JC. Medication management strategy for older people with polypharmacy in general practice: a qualitative study on prescribing behaviour in primary care. Br J Gen Pract. 2016;66(649):e540–51.
Weissenborn M, Haefeli WE, Peters-Klimm F, Seidling HM. Interprofessional communication between community pharmacists and general practitioners: a qualitative study. Int J Clin Pharm. 2017;39(3):495–506.
De Gier JJ. Commentaren Medicatiebewaking Pharmacom Stichting Health Base. Houten: Data Partners BV; 1986.
van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc. 2006;13(2):138–47.
Bates DW, Kuperman GJ, Wang S, Gandhi T, Kittler A, Volk L, et al. Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc. 2003;10(6):523–30.
Eickhoff C, Griese-Mammen N, Müeller U, Said A, Schulz M. Primary healthcare policy and vision for community pharmacy and pharmacists in Germany. Pharm Pract (Granada). 2021;19(1):2248.
Weda M, Hoebert J, Vervloet M, Puigmarti CM, Damen N, Marchange S, et al. Study on off-label use of medicinal products in the European Union: European Commission; 2017. https://ec.europa.eu/health/sites/default/files/files/documents/2017_02_28_final_study_report_on_off-label_use_.pdf. Accessed 11 May 2021
Conflicts of interest
Maaike M. E. Diesveld, Suzanne de Klerk and Sander D. Borgsteede are employed at Health Base Foundation (HBF), an independent, non-commercial foundation that maintains a drug information database (Pharmabase) and supports health care professional with a clinical decision support system. The drug-disease interactions studied in this manuscript are subject to medical information provided by HBF.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Diesveld, M.M.E., de Klerk, S., Cornu, P. et al. Management of drug-disease interactions: a best practice from the Netherlands. Int J Clin Pharm 43, 1437–1450 (2021). https://doi.org/10.1007/s11096-021-01308-0